前言
近年来，药物洗脱支架（drug-eluting stent, DES)已广泛用于急性心肌梗死的直接经皮冠状动脉介入治疗（percutaneous coronary intervention, PCI)。www.51lunwen.org/medicine/bsorbable polymercoating in human coronary arteries. Catheter Cardiovasc Interv. 2007 Feb1 ;69(2): 198-202.
[5] Han Y, Jing Q, Xu B, Yang L, Liu H, Shang X， Jiang T, Li Z, Zhang H， Li H, Qiu J，Liu Y， Li Y, Chen X, Gao R; CREATE (Multi-Center Registry of ExcelBiodegradable Polymer Drug-Eluting Stents) Investigators. Safety and efficacy ofbiodegradable polymer-coated sirolimus-eluting stents in "real-world" practice:18-month clinical and 9-month angiographic outcomes. JACC Cardiovasc Interv.2009Apr;2(4):303-9.
[6] Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Juni P, Vaina S, et al.Incidence and correlates of drug-eluting stent thrombosis in routine clinicalpractice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol.2008; 52(14): 1134-1140.
[7] Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, et al. Analysisof 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl JMed. 2007; 356(10): 1030-1039.
[8] Stone GW, Moses JW, Ellis SG, Schofer J， Dawkins KD， Morice MC, et al. Safetyand efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med.2007; 356(10): 998-1008.
[9] Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW.Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J AmColl Cardiol. 2005; 45(12): 2088-2092.
[10] Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, et al. Frequency of andrisk factors for stent thrombosis after drug-eluting stent implantation duringlong-term follow-up. Am J Cardiol. 2006; 98(3): 352-356.
